Stimuli-Responsive Nasal in situ Gel Drug Delivery Systems: from Material Design to Clinical Translation
Abstract
As a novel drug delivery system responsive to environmental stimuli (temperature, pH, ionic strength, etc). nasal in situ gels undergo phase transition to provide breakthrough solutions for precision and long-term management of nasal disorders through the integration of targeted therapy and sustained-release technology. Following nasal administration, the liquid formulation rapidly transforms into a semi-solid gel depot on the mucosal surface, significantly prolonging drug residence time and reducing drug loss due to mucociliary clearance. This process enhances local drug concentration and therapeutic persistence. Incorporating mucoadhesive technology and controlled-release drug-loading systems, this platform enables precise delivery of anti-inflammatory, antihistaminic, and immunomodulatory agents to lesion sites. It effectively mitigates systemic side effects (e.g. drowsiness, hepatic/renal burden) associated with conventional dosage forms while reinforcing nasal mucosal barrier repair. Clinical studies confirm its superior efficacy and safety profile in conditions requiring long-term therapy, including allergic rhinitis, sinusitis, and central nervous system disorders. Its mild gelation properties enhance patient tolerance, and single/every-other-day dosing regimens significantly improve compliance. Further optimization of release kinetics through multi-level drug-loading techniques (e.g. composite nanoparticles) demonstrates potential in gene therapy and vaccine…
Read the paper
Related studies
- Pharmacokinetic aspects of retinal drug delivery
- A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
- From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics
- Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus
- In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus
- Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.